Contrast-Enhanced Mammography (CEM) is a dual-energy radiographic technique that combines a standard mammogram with an intravenous iodinated contrast injection to visualize tumor-induced angiogenesis. By acquiring low-energy and high-energy image pairs post-contrast, CEM generates a recombined image that subtracts background parenchymal tissue, leaving only regions of contrast uptake. This functional information reveals the kinetic behavior of lesions, distinguishing hypervascular malignancies from benign or avascular structures.
Glossary
Contrast-Enhanced Mammography (CEM)

What is Contrast-Enhanced Mammography (CEM)?
A functional breast imaging technique that uses an intravenous iodinated contrast agent to highlight areas of neoangiogenesis, making hypervascular malignant lesions conspicuous against normal tissue.
The technique relies on the principle that malignant tumors secrete angiogenic factors to recruit a chaotic network of leaky microvessels. The iodinated agent rapidly extravasates into the tumor interstitium, creating transient enhancement. CEM captures this window with temporal precision, enabling kinetic curve analysis where rapid wash-in and washout patterns serve as highly specific indicators of malignancy. Compared to standard Full-Field Digital Mammography (FFDM), CEM provides physiological contrast that can unmask cancers obscured by dense fibroglandular tissue.
Key Features of CEM
Contrast-Enhanced Mammography (CEM) combines intravenous iodinated contrast with dual-energy digital mammography to visualize tumor neoangiogenesis. The technique produces both a standard low-energy image (anatomically equivalent to FFDM) and a recombined iodine map, making hypervascular malignant lesions conspicuous against normal breast parenchyma.
Dual-Energy Subtraction Imaging
CEM acquires a low-energy (26–32 kVp) and a high-energy (45–49 kVp) image in rapid succession following contrast injection. A weighted subtraction algorithm cancels the signal from background breast tissue, generating a recombined image that isolates iodine uptake. This dual-exposure technique exploits the k-edge of iodine (33.2 keV) to maximize contrast-to-noise ratio while minimizing motion artifact between acquisitions.
Neoangiogenesis Visualization
Malignant tumors secrete vascular endothelial growth factor (VEGF), stimulating the formation of leaky, tortuous capillaries. The iodinated contrast agent extravasates through these permeable vessel walls, accumulating in the tumor interstitium. CEM directly visualizes this hypervascularity, providing functional information that complements the morphological detail of standard mammography. This mechanism is identical to the enhancement principle in breast MRI.
Kinetic Curve Analysis
CEM supports temporal evaluation of contrast dynamics when multiple post-contrast acquisitions are obtained:
- Type I (Persistent): Progressive enhancement over time, typically benign
- Type II (Plateau): Rapid initial uptake followed by a stable phase, indeterminate
- Type III (Washout): Rapid uptake with early washout, highly suggestive of malignancy
A washout curve demonstrates high positive predictive value for invasive carcinoma.
Low-Energy / Recombined Image Pair
Every CEM examination yields two complementary views:
- Low-Energy Image: Anatomically identical to a standard FFDM mammogram; used for morphological assessment and BI-RADS classification
- Recombined (Iodine) Image: Displays only areas of contrast uptake; suppresses background parenchymal enhancement
Radiologists interpret both images side-by-side, correlating structural distortion on the low-energy view with functional enhancement on the recombined view.
Background Parenchymal Enhancement (BPE)
Normal fibroglandular tissue also enhances after contrast administration, a phenomenon termed background parenchymal enhancement. BPE is influenced by hormonal status, menstrual cycle phase, and exogenous hormone therapy. High BPE can mask small enhancing lesions and reduce diagnostic sensitivity. CEM protocols recommend scheduling premenopausal patients during the follicular phase (days 7–14) to minimize confounding enhancement.
Clinical Indications & Contraindications
Primary Indications:
- Preoperative staging to assess disease extent and detect multifocal/multicentric disease
- Problem-solving for equivocal findings on FFDM or DBT
- Evaluating response to neoadjuvant chemotherapy
- Contraindication to MRI (claustrophobia, pacemaker, severe obesity)
Contraindications:
- Prior severe allergic reaction to iodinated contrast
- Renal insufficiency (eGFR < 30 mL/min/1.73m²)
- Pregnancy
CEM vs. Other Breast Imaging Modalities
Functional and structural comparison of contrast-enhanced mammography against standard breast imaging techniques
| Feature | CEM | FFDM | DBT | Breast MRI |
|---|---|---|---|---|
Imaging Dimension | 2D + functional | 2D | 3D (pseudo-tomographic) | 3D volumetric |
Contrast Agent Required | ||||
Neoangiogenesis Visualization | ||||
Kinetic Curve Analysis | ||||
Tissue Overlap Artifact | Moderate | High | Low | Minimal |
Exam Duration | 7–10 min | 5–10 min | 10–15 min | 30–45 min |
Sensitivity (Dense Breast) | 91–93% | 62–70% | 85–90% | 93–100% |
Specificity | 65–87% | 90–95% | 85–92% | 37–72% |
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.

Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.

Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
Frequently Asked Questions
Explore the fundamental concepts, clinical applications, and technical mechanisms behind Contrast-Enhanced Mammography (CEM), a functional imaging modality that leverages iodinated contrast agents to reveal tumor neoangiogenesis.
Contrast-Enhanced Mammography (CEM) is a functional breast imaging technique that combines intravenous iodinated contrast administration with dual-energy digital mammography to visualize areas of neoangiogenesis—the abnormal formation of new blood vessels that supply malignant tumors. The procedure works by acquiring a pair of low-energy (below the k-edge of iodine, ~33.2 keV) and high-energy (above the k-edge) exposures in rapid succession following contrast injection. A weighted logarithmic subtraction algorithm then cancels out the background anatomy of the unenhanced breast tissue, leaving a recombined image that exclusively highlights regions of contrast uptake. Because malignant lesions typically exhibit hypervascularity and increased capillary permeability, they appear as focal areas of enhancement against a suppressed anatomical background. This mechanism effectively converts a standard anatomical mammogram into a functional map of perfusion, bridging the gap between conventional mammography and breast MRI.
Related Terms
Key concepts and techniques that intersect with Contrast-Enhanced Mammography to form a complete diagnostic workflow.
Kinetic Curve Analysis
The temporal evaluation of contrast agent uptake and washout patterns in CEM. Malignant lesions typically exhibit rapid initial enhancement followed by early washout (Type III curve), while benign findings show persistent or plateau enhancement. This functional data complements the morphological information from the low-energy image.
Neoangiogenesis
The biological process by which malignant tumors stimulate the formation of new, chaotic blood vessels to support rapid growth. These vessels are hyperpermeable and tortuous, causing the iodinated contrast agent to leak into the interstitial space. CEM directly visualizes this hallmark of malignancy, making hypervascular lesions conspicuous against normal parenchyma.
Dual-Energy Subtraction
The core physics technique enabling CEM. Two exposures are acquired at low energy (below the K-edge of iodine at 33.2 keV) and high energy (above it). A weighted logarithmic subtraction isolates the iodine signal while suppressing background breast tissue, generating a recombined image that highlights areas of contrast uptake.
Background Parenchymal Enhancement (BPE)
The normal physiological enhancement of fibroglandular tissue following contrast administration. BPE varies with hormonal status and can mask or mimic malignancy. Quantitative AI analysis of BPE extent and symmetry is critical for reducing false positives and distinguishing diffuse benign enhancement from focal suspicious lesions.
Low-Energy vs. Recombined Image
CEM produces two key outputs:
- Low-Energy Image: Equivalent to a standard 2D mammogram, used for morphological assessment
- Recombined Image: The iodine-specific subtraction image showing contrast uptake Radiologists read both simultaneously, correlating anatomical structure with functional vascularity to characterize lesions.

About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us